Achilles Therapeutics plc
ACHL · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $36 | $35 | $144 | $672 |
| - Cash | $132 | $173 | $266 | $178 |
| + Debt | $5 | $9 | $12 | $16 |
| Enterprise Value | -$91 | -$130 | -$110 | $510 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$5 | -$4 | -$3 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$70 | -$67 | -$61 | -$33 |
| % Margin | – | – | – | – |
| Net Income | -$70 | -$71 | -$61 | -$33 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.74 | -1.82 | -2.13 | -0.82 |
| % Growth | 4.4% | 14.6% | -159.8% | – |
| Operating Cash Flow | -$48 | -$60 | -$59 | -$25 |
| Capital Expenditures | -$1 | -$8 | -$8 | -$12 |
| Free Cash Flow | -$50 | -$67 | -$67 | -$37 |